China NMPA approves Keymed Biosciences’ sNDA for Stapokibart to treat chronic rhinosinusitis with nasal polyposis: Chengdu, China Thursday, December 26, 2024, 18:00 Hrs [IST] Ke ...

Changes are coming to the cold and cough aisle of your local pharmacy: U.S. officials are moving to phase out the leading ...

The FDA has proposed revoking the use of phenylephrine in pills and liquid solutions, citing its lack of effectiveness in relieving nasal congestion, and is requiring drugmakers to remove or ...